Literature DB >> 14747578

Distribution of hydrophobic residues is crucial for the fusogenic properties of the Ebola virus GP2 fusion peptide.

B Adam1, L Lins, V Stroobant, A Thomas, R Brasseur.   

Abstract

The lipid-destabilizing properties of the N-terminal domain of the GP2 of Ebola virus were investigated. Our results suggest that the domain of Ebola virus needed for fusion is shorter than that previously reported. The fusogenic properties of this domain are related to its oblique orientation at the lipid/water interface owing to an asymmetric distribution of the hydrophobic residues when helical.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14747578      PMCID: PMC369453          DOI: 10.1128/jvi.78.4.2131-2136.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  33 in total

Review 1.  Fusion peptides and the mechanism of viral fusion.

Authors:  Richard M Epand
Journal:  Biochim Biophys Acta       Date:  2003-07-11

2.  Hydrophobic cluster analysis: an efficient new way to compare and analyse amino acid sequences.

Authors:  C Gaboriaud; V Bissery; T Benchetrit; J P Mornon
Journal:  FEBS Lett       Date:  1987-11-16       Impact factor: 4.124

3.  Differentiation of lipid-associating helices by use of three-dimensional molecular hydrophobicity potential calculations.

Authors:  R Brasseur
Journal:  J Biol Chem       Date:  1991-08-25       Impact factor: 5.157

4.  Fusogenic activity of SIV (simian immunodeficiency virus) peptides located in the GP32 NH2 terminal domain.

Authors:  I Martin; F Defrise-Quertain; V Mandieau; N M Nielsen; T Saermark; A Burny; R Brasseur; J M Ruysschaert; M Vandenbranden
Journal:  Biochem Biophys Res Commun       Date:  1991-03-29       Impact factor: 3.575

5.  Molecular modeling of the amphipathic helices of the plasma apolipoproteins.

Authors:  R Brasseur; L Lins; B Vanloo; J M Ruysschaert; M Rosseneu
Journal:  Proteins       Date:  1992-07

6.  Correlation between fusogenicity of synthetic modified peptides corresponding to the NH2-terminal extremity of simian immunodeficiency virus gp32 and their mode of insertion into the lipid bilayer: an infrared spectroscopy study.

Authors:  I Martin; M C Dubois; F Defrise-Quertain; T Saermark; A Burny; R Brasseur; J M Ruysschaert
Journal:  J Virol       Date:  1994-02       Impact factor: 5.103

7.  Calcium-dependent conformational changes of membrane-bound Ebola fusion peptide drive vesicle fusion.

Authors:  Tatiana Suárez; María J Gómara; Félix M Goñi; Ismael Mingarro; Arturo Muga; Enrique Pérez-Payá; José L Nieva
Journal:  FEBS Lett       Date:  2003-01-30       Impact factor: 4.124

8.  H+- and Ca2+-induced fusion and destabilization of liposomes.

Authors:  H Ellens; J Bentz; F C Szoka
Journal:  Biochemistry       Date:  1985-06-18       Impact factor: 3.162

9.  Fusogenic segments of bovine leukemia virus and simian immunodeficiency virus are interchangeable and mediate fusion by means of oblique insertion in the lipid bilayer of their target cells.

Authors:  V Vonèche; D Portetelle; R Kettmann; L Willems; K Limbach; E Paoletti; J M Ruysschaert; A Burny; R Brasseur
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-01       Impact factor: 11.205

10.  Theoretical and functional analysis of the SIV fusion peptide.

Authors:  M Horth; B Lambrecht; M C Khim; F Bex; C Thiriart; J M Ruysschaert; A Burny; R Brasseur
Journal:  EMBO J       Date:  1991-10       Impact factor: 11.598

View more
  11 in total

1.  Studies on viral fusion peptides: the distribution of lipophilic and electrostatic potential over the peptide determines the angle of insertion into a membrane.

Authors:  A Taylor; M S P Sansom
Journal:  Eur Biophys J       Date:  2010-05-25       Impact factor: 1.733

Review 2.  Learning from the viral journey: how to enter cells and how to overcome intracellular barriers to reach the nucleus.

Authors:  Diky Mudhakir; Hideyoshi Harashima
Journal:  AAPS J       Date:  2009-02-05       Impact factor: 4.009

Review 3.  Structures and mechanisms of viral membrane fusion proteins: multiple variations on a common theme.

Authors:  Judith M White; Sue E Delos; Matthew Brecher; Kathryn Schornberg
Journal:  Crit Rev Biochem Mol Biol       Date:  2008 May-Jun       Impact factor: 8.250

Review 4.  Rodent-Adapted Filoviruses and the Molecular Basis of Pathogenesis.

Authors:  Logan Banadyga; Michael A Dolan; Hideki Ebihara
Journal:  J Mol Biol       Date:  2016-05-14       Impact factor: 5.469

5.  Plasma membrane localization of Solanum tuberosum remorin from group 1, homolog 3 is mediated by conformational changes in a novel C-terminal anchor and required for the restriction of potato virus X movement].

Authors:  Artemis Perraki; Jean-Luc Cacas; Jean-Marc Crowet; Laurence Lins; Michel Castroviejo; Sylvie German-Retana; Sébastien Mongrand; Sylvain Raffaele
Journal:  Plant Physiol       Date:  2012-08-01       Impact factor: 8.340

Review 6.  Filovirus entry: a novelty in the viral fusion world.

Authors:  Catherine L Hunt; Nicholas J Lennemann; Wendy Maury
Journal:  Viruses       Date:  2012-02-07       Impact factor: 5.048

Review 7.  Molecular mechanisms of Ebola virus pathogenesis: focus on cell death.

Authors:  L Falasca; C Agrati; N Petrosillo; A Di Caro; M R Capobianchi; G Ippolito; M Piacentini
Journal:  Cell Death Differ       Date:  2015-05-29       Impact factor: 15.828

Review 8.  Host cell factors in filovirus entry: novel players, new insights.

Authors:  Heike Hofmann-Winkler; Franziska Kaup; Stefan Pöhlmann
Journal:  Viruses       Date:  2012-12       Impact factor: 5.048

Review 9.  The three lives of viral fusion peptides.

Authors:  Beatriz Apellániz; Nerea Huarte; Eneko Largo; José L Nieva
Journal:  Chem Phys Lipids       Date:  2014-04-02       Impact factor: 3.329

Review 10.  Advances in Designing and Developing Vaccines, Drugs, and Therapies to Counter Ebola Virus.

Authors:  Kuldeep Dhama; Kumaragurubaran Karthik; Rekha Khandia; Sandip Chakraborty; Ashok Munjal; Shyma K Latheef; Deepak Kumar; Muthannan Andavar Ramakrishnan; Yashpal Singh Malik; Rajendra Singh; Satya Veer Singh Malik; Raj Kumar Singh; Wanpen Chaicumpa
Journal:  Front Immunol       Date:  2018-08-10       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.